Loading... Please wait...
Contact Us
Would you like more
information on this report
Please contact us today at +44(0)20.7665.9240
or +1 212.220.0880
or write to us.

Harnessing the Power of Big Data and Analytics in Medical Affairs

Product Code:
596200490
Publication Date:
June 2016
Format:
PDF
Price:
$695

Harness big data insights to improve medical affairs outcomes

Medical affairs teams are uniquely placed to apply insights from big data in a range of areas from improving KOL engagement to generate persuasive real world evidence.  Yet defining what data is needed, wisely selecting vendor/technology partners and managing the burden of compliance are hurdles that must be overcome.

Clear outcomes are critical if big data isn’t to become a big problem and this report examines the essentials for planning, commissioning and delivering successful big data projects in medical affairs.  Learn from experts where big data can make an impact now and in the future and identify the pitfalls to avoid. 

 

“I think a medical affairs organisation is uniquely positioned within a company as a centralised organisation that has different arms that touch everything else”
Senior VP
Global Medical Affairs and Strategic Partnerships
International Myeloma Foundation

Answering Key Questions

  • Before you start: What are the key considerations when planning a big data project to support medical affairs?
  • KOL engagement: How is big data analytics radically and positively impacting KOL identification and engagement strategies?
  • Getting real: How and where can big data used by medical affairs teams to generate real world evidence?
  • Data Security: What are the compliance and data security issues when internally sharing big data and analysis results that medical affairs professionals need to know?
  • Technology Partnering: What are the critical issues for medical affairs managers when selecting a technology partner to deliver an integrated big data solution?
  • All in it together? Pharma companies all hold vast databases of patient and disease information-- will the sharing of this data between companies’ medical affairs teams ever become a reality?
  • Resource Optimisation: How can big data solutions free-up hard-pressed medical affairs teams to focus on more valuable work?

 

Key Topics Explored

  • Is medical affairs the guardian of a centralised big data resource? Depending on where a product is in its lifecycle, the medical affairs team may interact with just about any other team internally.
  • While insights from big data may be global in application, medical affairs managers need to appreciate the stark differences in US and EU privacy laws that govern its collection and use.
  • Collecting and sharing patient level data - the challenges and opportunities for medical affairs
  • A big data system represents a considerable investment and medical affairs staff need to understand how to use it effectively. Training is essential if optimum value is to be gained. 

 

Expert contributors

In order to ensure candid views were expressed the names of some industry experts have been kept anonymous.
  • Medical Director, US
  • SVP, Global Medical Affairs and Strategic Partnerships, International Myeloma Foundation, US 
  • VP, Medical and Scientific Affairs, US 
  • VP, Medical Affairs, US 
  • Carlos Moreira, US Lead for Data and Analytics, PricewaterhouseCoopers (PwC)
  • Gary Tyson, Managing Partner, Pharma Initiatives, US
  • Medical Affairs Consultant, UK 
  • Leilani Latimer, Sr. Director, Global Marketing, Zephyr Health, US 

Need more information? Contact a consultant for an executive summary and sample pages from the report.

Contact Us

Harness big data insights to improve medical affairs outcomes

Medical affairs teams are uniquely placed to apply insights from big data in a range of areas from improving KOL engagement to generate persuasive real world evidence.  Yet defining what data is needed, wisely selecting vendor/technology partners and managing the burden of compliance are hurdles that must be overcome.

Clear outcomes are critical if big data isn’t to become a big problem and this report examines the essentials for planning, commissioning and delivering successful big data projects in medical affairs.  Learn from experts where big data can make an impact now and in the future and identify the pitfalls to avoid. 

 

“I think a medical affairs organisation is uniquely positioned within a company as a centralised organisation that has different arms that touch everything else”
Senior VP
Global Medical Affairs and Strategic Partnerships
International Myeloma Foundation

Answering Key Questions

  • Before you start: What are the key considerations when planning a big data project to support medical affairs?
  • KOL engagement: How is big data analytics radically and positively impacting KOL identification and engagement strategies?
  • Getting real: How and where can big data used by medical affairs teams to generate real world evidence?
  • Data Security: What are the compliance and data security issues when internally sharing big data and analysis results that medical affairs professionals need to know?
  • Technology Partnering: What are the critical issues for medical affairs managers when selecting a technology partner to deliver an integrated big data solution?
  • All in it together? Pharma companies all hold vast databases of patient and disease information-- will the sharing of this data between companies’ medical affairs teams ever become a reality?
  • Resource Optimisation: How can big data solutions free-up hard-pressed medical affairs teams to focus on more valuable work?

Key Topics Explored

  • Is medical affairs the guardian of a centralised big data resource? Depending on where a product is in its lifecycle, the medical affairs team may interact with just about any other team internally.
  • While insights from big data may be global in application, medical affairs managers need to appreciate the stark differences in US and EU privacy laws that govern its collection and use.
  • Collecting and sharing patient level data - the challenges and opportunities for medical affairs
  • A big data system represents a considerable investment and medical affairs staff need to understand how to use it effectively. Training is essential if optimum value is to be gained. 

Expert contributors

In order to ensure candid views were expressed the names of some industry experts have been kept anonymous.

  • Medical Director, US
  • SVP, Global Medical Affairs and Strategic Partnerships, International Myeloma Foundation, US 
  • VP, Medical and Scientific Affairs, US 
  • VP, Medical Affairs, US 
  • Carlos Moreira, US Lead for Data and Analytics, PricewaterhouseCoopers (PwC)
  • Gary Tyson, Managing Partner, Pharma Initiatives, US
  • Medical Affairs Consultant, UK 
  • Leilani Latimer, Sr. Director, Global Marketing, Zephyr Health, US 

Contact Us




customer.service@firstwordpharma.com

All Contents Copyright © 2017 Doctor's Guide Publishing Limited All Rights Reserved